Our site is currently under maintenance. We apologize for any issues this may cause.

Mydecine Innovations Group
Home
Our Work
  • Approach
  • Values
Investors
  • News
  • Stock Info
  • Presentation
About Us
  • Our Company
  • Careers
  • Contact
Mydecine Innovations Group
Home
Our Work
  • Approach
  • Values
Investors
  • News
  • Stock Info
  • Presentation
About Us
  • Our Company
  • Careers
  • Contact
More
  • Home
  • Our Work
    • Approach
    • Values
  • Investors
    • News
    • Stock Info
    • Presentation
  • About Us
    • Our Company
    • Careers
    • Contact
  • Home
  • Our Work
  • Investors
  • About Us

Our Approach

Drug Development

We have a robust portfolio of multiple pending patents for innovative first- and second-generation medications with a focus on safety and efficacy, as well as an excellent R&D staff and cutting-edge research facilities in Canada and the United States.

Learn more

Clinical Trials

We've collaborated with leading worldwide research institutions to examine a number of medication candidates with the potential for greater effectiveness and other enhancements. The first clinical studies will focus on nicotine dependency and PTSD.

Learn more

Technology

Technology is an important part of our business strategy, and we're using artificial intelligence and machine learning to scan billions of molecules for potential novel compounds. 

Learn more

hello@mydecineinc.com | +1 (720) 277-9879

US: 1250 S. Parker Rd., Ste A, Denver, CO 80231

CA: 905 West Pender Street, 6th Floor,Vancouver, BC V6C 1L6


Copyright © 2020-2022 Mydecine Innovations Group - All Rights Reserved.

  • Privacy Policy
  • Terms of Use

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept